Insertion/Deletion polymorphism of Angiotensin-converting enzyme as a risk factor for chronic allograft nephropathy (Q42943601)

11 November 2017

title

Insertion/Deletion polymorphism of Angiotensin-converting enzyme as a risk factor for chronic allograft nephropathy (English)

1 reference

11 November 2017

8

1 reference

11 November 2017

R Fedor

1

1 reference

11 November 2017

L Asztalos

2

1 reference

11 November 2017

L Löcsey

3

1 reference

11 November 2017

L Szabó

4

1 reference

11 November 2017

I S Mányiné

5

1 reference

11 November 2017

M Fagyas

6

1 reference

11 November 2017

E Lizanecz

7

1 reference

11 November 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

Transplantation Proceedings

11 November 2017

published in

1 reference

11 November 2017

volume

42

1 reference

11 November 2017

issue

6

1 reference

11 November 2017

page(s)

2304-2308

1 reference

Banff 07 classification of renal allograft pathology: updates and future directions

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

The aetiology and pathogenesis of chronic allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

Angiotensin-converting enzyme inhibitors after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

Angiotensin converting enzyme inhibition in chronic allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

The benefits of renin-angiotensin blockade in renal transplant recipients with biopsy-proven allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

Angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

Angiotensin-converting enzyme gene I/D polymorphism and renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

Impact of genetic polymorphisms of the renin-angiotensin system and of non-genetic factors on kidney transplant function--a single-center experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

Combination of Angiotensin-Converting Enzyme and Methylenetetrahydrofolate Reductase Gene Polymorphisms as Determinant Risk Factors for Chronic Allograft Dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

Association of hypertension genotypes and decline in renal function after kidney transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

Association of the genetic polymorphisms of the renin-angiotensin system with kidney graft long-term outcome: preliminary results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

Angiotensin-Converting Enzyme Gene Polymorphism in Chronic Allograft Nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

Role of ACE gene polymorphism on cardiovascular complications after renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

Polymorphism of the renin-angiotensin-aldosterone system in patients with chronic allograft dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

Association of the genetic polymorphisms of the renin-angiotensin system and endothelial nitric oxide synthase with chronic renal transplant dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

Angiotensin Converting Enzyme Genotype and Chronic Allograft Nephropathy in Protocol Biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

The influence of angiotensin-converting enzyme gene of donor and recipient on the function of transplanted kidney.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2010.05.020

10.1016/J.TRANSPROCEED.2010.05.020

7 January 2021

Identifiers

DOI

1 reference

11 November 2017

1 reference